1-3 of 3
Annie Le Mevel, MD
Close
Sort by
Journal Articles

Phase I/II Study of Escalating Doses of Idarubicin in Combination with Methotrexate, Vindesine and Prednisolone in Patients with Primary Central Nervous System Lymphoma: Results of the GOELAMS LCP99 Multicenter Trial.

Gaelle Olivier, MD, Martine Gardembas, MD, Vincent Delwail, MD, Annie Le Mevel, MD, Martine Escoffre-Barbe, MD, Annie Brion, MD, Jean Michel Boulet, MD, Philippe Solal-Celigny, MD, Pierre Ingrand, MD, Philippe Colombat, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2694.
https://doi.org/10.1182/blood.V114.22.2694.2694
Published: 2009
Journal Articles

Interim Results of the RiPAD+C Regimen Including Velcade in Front Line Therapy for Elderly Patients with Mantle Cell Lymphoma. A Phase II Prospective Study of the GOELAMS Group.

Remy Gressin, MD, Sylvie caulet Maugendre, MD, Steven Le Gouill, MD, Mario ojeda Uribe, MD, Magda Alexis Vigier, MD, Krimo Bouabdallah, Christiane Mounier, Olivier Tournilhac, MD, Philippe Rodon, MD, Abderrazak El Yamani, Laurent Sutton, Delphine Senecal, MD, Bruno Lioure, MD, David Assouline, MD, Annie Le Mevel, MD, Bruno Villemagne, MD, Charles Dauriac, MD, Martine Gardembas, MD, Sophie Park, MD, Thierry Lamy, PhD
Journal: Blood
Blood (2008) 112 (11): 1575.
https://doi.org/10.1182/blood.V112.11.1575.1575
Published: 2008
Journal Articles

Late Relapse of Localized High-Grade Non-Hodgkin’s Lymphoma: Clinical and Biological Features

Gandhi Damaj, MD, Marc Bernard, MD, Steven Legouill, MD, Guillaume Cartron, MD, PhD, Annie Le Mevel, MD, Céline Dubus, Christian Berthou, MD, PhD, Philippe Colombat, MD, PhD, Noel Milpied, MD, PhD, Jean Pierre Marolleau, MD, PhD, Thierry Lamy, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2603.
https://doi.org/10.1182/blood.V112.11.2603.2603
Published: 2008